Inhalers may be prescribed to people who have a variety of health conditions both chronic and acute, including asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. If you're new to ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...

GRAND RAPIDS, Mich. (WOOD) — Many people manage their asthma with an inhaler — but they may not be using it correctly. Studies show that nearly 90% of patients with an inhaler make at least one ...

The pros and cons to using a dry powder inhaler as treatment for chronic obstructive pulmonary disease. Neil Minkoff, MD: Dr Drummond, we’ve talked a little bit about the differences. You brought some ...

A total of 45% of patients made at least 1 error when using an inhaler, and the number of errors per patient ranged from 1 to 6. While inhaled therapies can reduce ...

Please provide your email address to receive an email when new articles are posted on . Patients were treated for grass, birch and/or mugwort pollen allergy. Patients with persistent allergic rhinitis ...

A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India.

Use of an electronic tool contributed to the deprescribing of unnecessary inhalers in patients with interstitial lung disease (ILD), based on data from nearly 200 individuals. Patients with ILD often ...

TEL AVIV, ISRAEL & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of AirDuo ® ...